Valuation: Stryker Corporation

Market Cap 128B 659B 112B 103B 96.51B 181B 12,032B 185B 1,239B 479B 5,946B 479B 468B 20,620B P/E 2026 *
26.2x
P/E 2027 * 22.9x
Enterprise Value 136B 704B 120B 110B 103B 193B 12,865B 198B 1,325B 513B 6,358B 512B 501B 22,047B EV / Sales 2026 *
5x
EV / Sales 2027 * 4.5x
Free-Float
94.62%
Yield 2026 *
1.08%
Yield 2027 * 1.16%
1 day+8.63%
1 week+9.47%
Current month+9.19%
1 month+8.54%
3 months-1.18%
6 months-13.68%
Current year-13.68%
1 week 75
Extreme 75
85.59
1 month 73.91
Extreme 73.91
85.59
Current year 69.77
Extreme 69.77
99.8
1 year 69.77
Extreme 69.77
112.5
3 years 64.71
Extreme 64.71
120.24
5 years 50.67
Extreme 50.666
120.24
10 years 44.61
Extreme 44.61
120.24
Manager TitleAgeSince
Chief Executive Officer 60 01/10/2012
Director of Finance/CFO 50 01/04/2025
President 49 01/01/2026
Director TitleAgeSince
Director/Board Member 82 01/01/1974
Director/Board Member 71 01/01/1984
Chairman 60 22/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
+8.63%+9.47% - - 128B
-0.65%+1.20%+2.66%-9.79% 12.77B
+1.30%+10.51%+42.40%+105.32% 8.48B
-3.88%-6.41%-50.35%-73.01% 3.79B
-0.38%-0.97%+17.82%+35.82% 2.52B
-9.06%+4.50%+217.06%+149.44% 1.55B
-8.75%-13.25%-26.08%-26.91% 1.53B
-2.80%-3.48%-1.60%-23.46% 1.53B
+5.22%+7.30%-65.47%-85.58% 1.32B
Average -1.15%-0.15%+17.05%+8.98% 4.18B
Weighted average by Cap. +6.60%+2.00%+13.62%+18.63%

Financials

2026 *2027 *
Net sales 27.27B 141B 23.91B 22.04B 20.63B 38.69B 2,572B 39.49B 265B 102B 1,271B 102B 100B 4,408B 29.58B 153B 25.94B 23.91B 22.38B 41.97B 2,791B 42.84B 287B 111B 1,379B 111B 109B 4,782B
Net income 4.84B 25.03B 4.25B 3.92B 3.67B 6.87B 457B 7.02B 47.06B 18.21B 226B 18.19B 17.8B 783B 5.54B 28.64B 4.86B 4.48B 4.19B 7.87B 523B 8.03B 53.85B 20.84B 258B 20.82B 20.36B 896B
Net Debt 8.83B 45.6B 7.74B 7.13B 6.68B 12.52B 833B 12.78B 85.75B 33.18B 412B 33.15B 32.42B 1,427B 5.47B 28.24B 4.79B 4.42B 4.14B 7.76B 516B 7.92B 53.1B 20.55B 255B 20.53B 20.08B 884B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
26/06/26 R$85.20 +13.60% 28
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
332.71USD
Average target price
386.80USD
Spread / Average Target
+16.26%

Quarterly revenue - Rate of surprise